El interés en corto de TC BioPharm (Holdings) da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de TC BioPharm (Holdings). Los datos de interés en corto se actualizan cada dos semanas.

TC BioPharm (Holdings) (NASDAQ:TCBP) Bolsa, Informe de interés en corto

TC BioPharm (Holdings)

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.

TC BioPharm (Holdings) plc - American Depositary Shares

TC BioPharm (Holdings) PLC

<ul>
<li>Muñoz to lead Hyundai Motor Company's global business</li>
<li>Continues to serve on the Hyundai Motor Company Board of Directors</li>
</ul>
Hyundai Motor Company (HMC) today announced the appointment of José Muñoz as the company's President and CEO, effective Jan. 1, 2025. Muñoz will lead Hyundai Motor Company's global business, succeeding current President and CEO Jaehoon Chang, who has been promoted to the Vice Chair of Hyundai Motor Group – Automotive Division.

News

Management

HYMLF

HYMTF

Reported Earlier, Hyundai Motor Company Names José Muñoz As President And Chief Executive Officer, Effective January 1, 2025

Macro Economic Events

Econ #s

Economics

France Harmonised Index of Consumer Prices (MoM) For October 0.3% Vs. 0.3% Est.; -1.3% Prior

France Consumer Price Index (MoM) For October 0.3% Vs. 0.2% Est.; -1.3% Prior

OneStream, Inc announced today the pricing of the previously announced underwritten public offering of 15,000,000 shares of its Class&nbsp;A common stock, at a public offering price of $31.00 per share, of which 9,006,948 shares will be sold by selling stockholders and 5,993,052 shares will be sold by OneStream as part of a non-dilutive "synthetic secondary" transaction (the "Synthetic Secondary").

Reported Earlier, OneStream Prices Secondary Offering Of 15M Class A Common Stock At $31/Share

Associated expects to use the net proceeds from this offering for general corporate purposes to support continued organic growth and capital generation, which may include investments in Associated Bank, N.A. and potential balance sheet optimization strategies.

Reported Earlier, Associated Banc-Corp Prices $300M Public Offering Of 12M Common Stock Offering At $25/Share

In a unique perspective, a cryptocurrency analyst equated Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) to gunpowder, arguing that sooner or later sovereign nations would be compelled to adopt the leading cryptocurrency.
What Happened: Matt Huang, CEO of cryptocurrency-focused investment firm Paradigm, penned a blog post Thursday, highlighting Bitcoin&#8217;s growing prominence. 
Huang argued that like gunpowder became indispensable after its discovery, the same would eventually pan out for emerging technologies like artificial intelligence, drones, and Bitcoin.
&#8220;Sovereigns can no longer afford to dismiss BTC. From a game theoretic perspective, BTC is like gunpowder, not the iPhone. Christopher,&#8221; the analyst remarked.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Bitcoin for the Sovereign <a href="https://t.co/HD1UpcD6J7">pic.twitter.com/HD1UpcD6J7</a>
&mdash; Matt Huang (@matthuang) <a href="https://twitter.com/matthuang/status/1857127295145902586?ref_src=twsrc%5Etfw">November 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Huang highlighted how calls for the establishment of a Bitcoin strategic reserve have intensified since Donald Trump&#8217;s presidential victory, suggesting the opening of the Overton window for Bitcoin acceptance in America.
&#8220;Sovereigns that build BTC reserves early will benefit from significantly better entry prices. The race to build BTC reserves is on.&#8221;
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41912787/buckle-up-for-the-bull-markets-most-fun-phase-says-industry-expert-bitcoin-ethereum-dogecoin-about-to-enter-the-euphoria-stage?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;Buckle Up&#8217; For The Bull Market&#8217;s &#8216;Most Fun Phase,&#8217; Says Industry Expert: Bitcoin, Ethereum, Dogecoin Abo</a>
Why It Matters: The Republican side vigorously promoted the idea of a Bitcoin reserve leading up to the elections, with none other than President-elect Trump <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40001426/trump-aims-to-make-us-crypto-capital-of-the-planet-well-get-it-done">vowing to establish one</a> if voted to power.
A few days later, Senator Cynthia Lummis (R-Wyo.) <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40087880/cynthia-lummis-unveils-strategic-bitcoin-reserve-legislation-this-is-our-louisiana-purchas">proposed </a>a bill, called the BITCOIN Act, aimed at creating a strategic Bitcoin stockpile to support America's balance sheet.
The senator reiterated her pledge following the Republican Party&#8217;s electoral triumph last week, as Polymarket odds showed a <a href="https://polymarket.com/event/will-trump-create-a-national-bitcoin-reserve-in-his-first-100-days?tid=1731494882651">35%</a> probability of this happening.
Moreover, emboldened by broader support, Pennsylvania introduced the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41986427/pennsylvania-introduces-bitcoin-strategic-reserve-act-to-invest-up-to-700-million-in-btc">Bitcoin Strategic Reserve Act</a>, hoping to build its own state-held Bitcoin reserve.
Price Action: At the time of writing, Bitcoin was trading at $87,824.55, down 2.35% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/41998869/analyst-says-bitcoin-lives-rent-free-in-peoples-minds-after-peter-schiffs-cheeky-social-security-trust-remark">Peter Schiff&#8217;s Cheeky Bitcoin Turnaround Post Earns Reaction From Popular Analyst: &#8216;You Buy It And Become Rich Or You Keep Hating And Turn Crazy&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

Bitcoin Is Like Gunpowder And That Is Why Sovereign States Can't Refuse Its Adoption, Says Crypto Analyst

Buybacks

SNDL

Reported Earlier, SNDL Extends Share Repurchase Program With C$100M Authorization, Aiming To Repurchase Up To 13.2M Shares

Equus Total Return, Inc. (NYSE:<a href="https://www.benzinga.com/stock/EQS#NYSE">EQS</a>) ("Equus" or the "Company") reports net assets as of September 30, 2024, of $40.2 million. Net asset value per share decreased to $2.96 as of September 30, 2024, from $3.66 as of June 30, 2024. Comparative data is summarized below (in thousands, except per share amounts):&nbsp;&nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>As of the Quarter Ended</td>
<td>9/30/2024</td>
<td>6/30/2024</td>
<td>3/31/2024</td>
<td>12/31/2023</td>
<td>9/30/2023 &nbsp;</td>
</tr>
<tr>
<td>Net assets</td>
<td>$40,165</td>
<td>$49,792</td>
<td>$45,892</td>
<td>$48,287</td>
<td>$47,128</td>
</tr>
<tr>
<td>Shares outstanding</td>
<td>13,586</td>
<td>13,586</td>
<td>13,586</td>
<td>13,586</td>
<td>13,518</td>
</tr>
<tr>
<td>Net assets per share</td>
<td>$2.96</td>
<td>$3.66</td>
<td>$3.38</td>
<td>$3.55</td>
<td>$3.49</td>
</tr>
</tbody>
</table>
</figure>

Reported Earlier, Equus Total Return Reports Net Assets As Of September 30, 2024, Of $40.2M; Net Asset Value Per Share $2.96

ZLAB

Reported Earlier, Zai Lab Prices 7.8M American Depositary Shares At $25.50/ADS In $200M Public Offering

Maui Land &amp; Pineapple Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLP#NYSE">MLP</a>) reported quarterly losses of $(0.07) per share. This is a 16.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $3.02 million in sales this quarter. This is a 43.98 percent increase over sales of $2.10 million the same period last year.

Earnings

Maui Land & Pineapple Co Q3 EPS $(0.07) Down From $(0.06) YoY, Sales $3.02M Up From $2.10M YoY

GreenPower Motor Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GP#NASDAQ">GP</a>) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. The company reported quarterly sales of $5.347 million which missed the analyst consensus estimate of $7.967 million by 32.88 percent. This is a 36.35 percent decrease over sales of $8.400 million the same period last year.

Earnings Misses

GreenPower Motor Co Q2 2025 GAAP EPS $(0.18) Misses $(0.16) Estimate, Sales $5.347M Miss $7.967M Estimate

Beam Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEEM#NASDAQ">BEEM</a>) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.12) by 175 percent. The company reported quarterly sales of $11.482 million which missed the analyst consensus estimate of $18.863 million by 39.13 percent. This is a 30.35 percent decrease over sales of $16.486 million the same period last year.

Earnings Beats

BEEM

Beam Global Q3 2024 GAAP EPS $0.09 Beats $(0.12) Estimate, Sales $11.482M Miss $18.863M Estimate

Lantmännen will invest more than 100 million euros in a state-of–the-art <a href="https://www.globenewswire.com/Tracker?data=D-7Y-KVbP6QZknfadXEZ-FyiOL801tmcb6MoPLIt1GBtRzzMxYqB5y0WMAfkDOuP8wF9RdBMPWvDS7IIKC_OkWudCUCt9vi-8ARGYU9fdadf5aFadydlfMoC2c0oEek0wq9shl6f0tFxH4iEsBbG2plhHfhgHB7WME97-NbSZIM6dfFRmaj3AkU_gZXrXeRD6wSfFlbL5NZEKQdFWd05Ix8BUt1dMN_MHpAiD0GLnSSve8knOhEkT3alPDLqD0Z4qqemEbKkxRZ3MJ3oKFuKXBYY26VDZ92n-tTgubAPhQo=">factory in Sweden</a>, while partnering with Ingredion to develop a differentiated portfolio of plant-based protein isolates based on yellow peas. Construction of the production plant will be completed in 2027.

INGR

Reported Earlier, Ingredion And Lantmännen Forge Strategic Alliance To Boost European Plant-Based Protein Market, Invest Over €100M In New Pea Protein Facility

U.K. Trade Balance Non-EU For September -5.31B Vs. -4.85B (Revised) Prior

U.K. Trade Balance For September -16.32B Vs. -15.70B Est.; -15.21B (Revised) Prior

U.K. Monthly Gross Domestic Product (GDP) 3M/3M Change For September 0.1% Vs. 0.2% Est.; 0.2% Prior

U.K. Manufacturing Production (MoM) For September -1.0% Vs. 0.0% Est.; 1.3% (Revised) Prior

U.K. Industrial Production (MoM) For September -0.5% Vs. 0.1% Est.; 0.5% Prior

U.K. Gross Domestic Product (QoQ) Preliminary For Q3 0.1% Vs. 0.2% Est.; 0.5% Prior

U.K. Gross Domestic Product (YoY) Preliminary For Q3 1.0% Vs. 0.1% Est.; 0.7% Prior

TC BioPharm regains compliance with Nasdaq

TC Biopharm files to sell 1.5M American depositary shares, warrants

TC Biopharm (Holdings) Plc Sponsored ADR (TCBP) has released an update. TC BioPharm (Holdings) Plc announced it has regained compliance with Nasdaq...

TC BioPharm Regains Nasdaq Compliance

TC Biopharm (Holdings) Plc Sponsored ADR (TCBP) has released an update. TC Biopharm (Holdings) Plc has issued a pre-funded warrant allowing holders...

TC Biopharm Unveils New Pre-Funded Warrant

TC BioPharm stock rallies 20% on Phase 2 study update

14:16 EDT TC Biopharm (TCBP) (Holdings) PLC – ADR trading halted, volatility trading pause Published first on TheFly – the ultimate source for real...

TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause

14:21 EDT TC Biopharm (TCBP) (Holdings) PLC – ADR trading resumes Published first on TheFly – the ultimate source for real-time, market-moving brea...

TC Biopharm (Holdings) PLC – ADR trading resumes

TC BioPharm (TCBP) announced it has entered into a research planning collaboration with Dr. Carlos Maluquer de Motes for the development of a treat...

TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes

The company said, "TC BioPharm (TCBP) refuted a false claim made earlier this week on social media, stating there is absolutely no way the company ...

TC Biopharm refutes social media claim, remains compliant with Nasdaq rules

TC BioPharm (TCBP) announced that it has been awarded non-dilutive funding of $250,000 from the G-Rex Grant Program. The G-ReX Grant Program, launc...

TC Biopharm awarded funding of $250,000 from G-Rex Grant Program

TCBP

Press Releases

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial

TCBP to Present at the 2024 ThinkEquity Conference in NYC

TCBP Announces Site Opening of Guys and St. Thomas Hospital

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

Contracts

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic

Cardiol Therapeutics' (NASDAQ: CRDL) CardiolRx™ Addresses Urgent Medical Condition Myocarditis, a Leading Cause of Sudden Cardiac Death see more stocks inside…

Comments

TC BioPharm (Holdings)

Interés en corto

TC BioPharm (Holdings) (NASDAQ:TCBP) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL